While the binding and inhibition of topoisomerase IIβ contributes to the cardioprotective activity of DEX in cardiomyocytes, it can also potentially bind and inhibit its sister isoform, topoisomerase IIα which is highly expressed in cancer cells (Yan et al., 2009; Deng et al., 2014). Here, TOP2B is linked to cancer.